About the Company
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BLPH News
Bellerophon Therapeutics Inc BLPH
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Bellerophon Therapeutics Stock Nosedive: Here's Why
Bellerophon Therapeutics Inc (NASDAQ: BLPH) announced top-line results from its pivotal Phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for fibrotic Interstitial Lung Disease ...
Bellerphon Therapeutics stock plunges toward record selloff after lung disease treatment performs worse than placebo in late-stage trial
Shares of Bellerophon Therapeutics Inc. plummeted 83% toward a record one-day decline, after the biotherapeutics company said its lung-disease treatment failed to meet its primary endpoint in a ...
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class ...
Frequency Electronics Stock (NASDAQ:FEIM), Quotes and News Summary
Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered ...
VHCP Management II, LLC's Net Worth
Who is VHCP Management II, LLC? VHCP Management II, LLC has an estimated net worth of $618 Million. This is based on reported shares across multiple companies, which include CONSTELLATION ...
ACRV Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific ...
CDTX Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin ...
Bellerophon Therapeutics Inc BLPH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bellerophon Therapeutics, Inc. (BLPH)
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Bellerophon Therapeutics, Inc. (BLPH)
Upgrade your Yahoo Finance plan to get complete details for Bellerophon Therapeutics, Inc. Get advanced tools and insights to navigate the markets.
Bellerophon Therapeutics, Inc. (BLPH)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...